Purchase disclosed
Donald Allen Williams
Director
Common Stock
- Reported value
- $14.2K
- Reported price
- $1.42 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
PALISADE BIO, INC.
Last 30 daysInsiders bought $28.8K · 1 buyer, led by Donald Allen Williams (Director) with $28.8K. No qualifying insider sales.
Showing the first 6 of 20 trades on this page.
Director
Common Stock
Director
Common Stock
$106,016 of common-equity purchase value after transaction-age decay across 180 days.
2 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.
A reporting-owner group bought on at least two distinct dates within the cluster window.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
CEO, CFO
Common Stock
The filing reports a zero transaction price for this gift. It does not establish the market value of the gift.
CEO, CFO
Common Stock
The filing reports a zero transaction price for this gift. It does not establish the market value of the gift.
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Chief Medical Officer
Common Stock
Chief Medical Officer
Common Stock
Chief Medical Officer
Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
CEO, CFO
Common Stock
CEO, CFO
Common Stock
CEO, CFO
Common Stock
CEO, CFO
Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
CEO, CFO
Series 2 Common Stock Purchase Warrant
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Director | Common StockPurchase | 10,000$1.42 / share | $14.2K | Oct 1Filed Oct 5 · 4d later | SEC filing |
| Director | Common StockPurchase | 10,000$1.46 / share | $14.6K | Oct 2Filed Oct 5 · 3d later | SEC filing |
| CEO, CFO | Common StockGift | 88,400Gift · no purchase price | Not a purchase | Aug 19Filed Aug 21 · 2d later | SEC filing |
| CEO, CFO | Common StockGift | 88,400Gift · no purchase price | Not a purchase | Aug 19Filed Aug 21 · 2d later | SEC filing |
| Director | Common StockPurchase | 20,000$1.99 / share | $39.8K | Jul 8Filed Jul 10 · 2d later | SEC filing |
| Director | Common StockPurchase | 25,000$1.96 / share | $48.9K | Jul 9Filed Jul 10 · 1d later | SEC filing |
| Director | Common StockPurchase | 20,000$2.05 / share | $41.04K | Jul 6Filed Jul 8 · 2d later | SEC filing |
| Director | Common StockPurchase | 30,000$2.03 / share | $61.04K | Jul 7Filed Jul 8 · 1d later | SEC filing |
| Chief Medical Officer | Common StockOption exercise or conversion | 131,167Price not reported | Unavailable | Jul 6Filed Jul 8 · 2d later | SEC filing |
| Chief Medical Officer | Common StockSale | 51,880$2.05 / share | $106.54K | Jul 7Filed Jul 8 · 1d later | SEC filing |
| Chief Medical Officer | Restricted Stock UnitsOption exercise or conversion | Derivative units131,167Exercise / conversion price not reported | Not a separate purchase | Jul 6Filed Jul 8 · 2d later | SEC filing |
| CEO, CFO | Common StockOption exercise or conversion | 335,167Price not reported | Unavailable | Jul 6Filed Jul 8 · 2d later | SEC filing |
| CEO, CFO | Common StockSale | 146,798$2.07 / share | $303.34K | Jul 7Filed Jul 8 · 1d later | SEC filing |
| CEO, CFO | Common StockOption exercise or conversion | 133$0.70 / share | $93.1 | Jul 7Filed Jul 8 · 1d later | SEC filing |
| CEO, CFO | Restricted Stock UnitsOption exercise or conversion | Derivative units335,167Exercise / conversion price not reported | Not a separate purchase | Jul 6Filed Jul 8 · 2d later | SEC filing |
| CEO, CFO | Series 2 Common Stock Purchase WarrantOption exercise or conversion | Derivative units133$0.70 exercise / conversion price | Not a separate purchase | Jul 7Filed Jul 8 · 1d later | SEC filing |
| Director | Common StockPurchase | 20,000$1.98 / share | $39.6K | Jul 1Filed Jul 6 · 5d later | SEC filing |
| Director | Common StockPurchase | 10,000$1.98 / share | $19.8K | Jul 2Filed Jul 6 · 4d later | SEC filing |
| Director | Common StockGrant or award | 336,904Price not reported | Unavailable | Jun 10Filed Jun 18 · 8d later | SEC filing |
| Director | Common StockGrant or award | 592,300Price not reported | Unavailable | Jun 10Filed Jun 12 · 2d later | SEC filing |
Showing the latest 20 of 29 trades. Show all 29 trades
This reflects the filings imported so far, not a complete trading history.